ConductScience.org, home

Paper29527331

Targeting oncogenic Myc as a strategy for cancer treatment.

Chen H and 2 others. Signal Transduct Target Ther, 2018. Cited by 665 papers, by iCite.

Cite this record

ConductScience Library. Targeting oncogenic Myc as a strategy for cancer treatment. Papers, record 29527331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29527331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting oncogenic Myc as a strategy for cancer treatment.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
665
iCite
Relative citation ratio, by iCite
22.2
iCite
Revised in PubMed
2022-03-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen HHui
2Liu HHudan
3Qing GGuoliang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121964340Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.Nature2011https://conductscience.org/library/papers/21964340PubMed
27824278Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.Oncogene1995https://conductscience.org/library/papers/7824278PubMed
320884625Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.Clin Cancer Res2010https://conductscience.org/library/papers/20884625PubMed
422982363Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription.Biochim Biophys Acta2013https://conductscience.org/library/papers/22982363PubMed
59824157Design and properties of a Myc derivative that efficiently homodimerizes.Oncogene1998https://conductscience.org/library/papers/9824157PubMed
617015432Control of cellular senescence by CPEB.Genes Dev2006https://conductscience.org/library/papers/17015432PubMed
716064138Transcriptional regulation and transformation by Myc proteins.Nat Rev Mol Cell Biol2005https://conductscience.org/library/papers/16064138PubMed
826528759Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.Oncotarget2015https://conductscience.org/library/papers/26528759PubMed
926390243Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.Nat Med2015https://conductscience.org/library/papers/26390243PubMed
1026186940Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.Blood2015https://conductscience.org/library/papers/26186940PubMed
1116935001Conditional transgenic models define how MYC initiates and maintains tumorigenesis.Semin Cancer Biol2006https://conductscience.org/library/papers/16935001PubMed
1223021215Transcriptional amplification in tumor cells with elevated c-Myc.Cell2012https://conductscience.org/library/papers/23021215PubMed
1328174256A Time for MYC: Metabolism and Therapy.Cold Spring Harb Symp Quant Biol2016https://conductscience.org/library/papers/28174256PubMed
1417606868Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.J Cell Biol2007https://conductscience.org/library/papers/17606868PubMed
1515930260Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy.Cancer Res2005https://conductscience.org/library/papers/15930260PubMed
161350857The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins.Nucleic Acids Res1992https://conductscience.org/library/papers/1350857PubMed
1725632068The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.Ann Oncol2015https://conductscience.org/library/papers/25632068PubMed
189552388The family of polo-like kinases.Prog Cell Cycle Res1996https://conductscience.org/library/papers/9552388PubMed
1918177721The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab2008https://conductscience.org/library/papers/18177721PubMed
2022464321MYC on the path to cancer.Cell2012https://conductscience.org/library/papers/22464321PubMed

See all 97 referencesDownload CSV of references

Cited by496

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 665 citations.

PMIDTitleJournalYearIn PapersSource
42966755Conformational heterogeneity: a fundamental mechanism of adaptive phenotypic plasticity and therapeutic resistance.Br J Cancer2026https://conductscience.org/library/papers/42966755PubMed
42934665From motion to molecules: exercise-triggered large EVs suppress oncogenic signaling in lung adenocarcinoma cells - an in vitro pilot study.Cancer Cell Int2026https://conductscience.org/library/papers/42934665PubMed
42540626Apatinib resistance mediated by IRF9 nuclear translocation in head and neck squamous cell carcinoma.iScience2026https://conductscience.org/library/papers/42540626PubMed
42536269Carbohydrates metabolic reprogramming and tumor microenvironment in pancreatic cancer: targeting pathways.Mol Biol Rep2026https://conductscience.org/library/papers/42536269PubMed
42490795Transcription Factor MAX Regulates Liver Cancer Cell Growth, Migration, Invasion, and Epithelial-Mesenchymal Transition by Promoting SF3A3 Expression.World J Oncol2026https://conductscience.org/library/papers/42490795PubMed
42426296Paediatric therapeutic development workshop on medulloblastoma.Br J Cancer2026https://conductscience.org/library/papers/42426296PubMed
42362505EphB4 inhibition defines a druggable synthetic-lethal vulnerability in MYC-driven triple-negative breast cancer.Cell Death Dis2026https://conductscience.org/library/papers/42362505PubMed
42346864c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities.Med Sci (Basel)2026https://conductscience.org/library/papers/42346864PubMed
42326536Single-cell gain-of-function mapping reveals latent regulatory programs governing CD8+ T cell fate.Res Sq2026https://conductscience.org/library/papers/42326536PubMed
42278393MYC_V1-Related Genes Affect Gastric Cancer Proliferation by Regulating Energy Metabolism and Analysis of Therapeutic Targets.Int J Mol Sci2026https://conductscience.org/library/papers/42278393PubMed
42247584No Time to Fold: Intrinsically Disordered Microproteins in Action.Biochemistry2026https://conductscience.org/library/papers/42247584PubMed
42224600Crotonylation impedes c-Myc oncogenic activity.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42224600PubMed
42199344Coconut oil/lauric acid-based nanodrug formulation: a multifunctional platform for enhancing cancer therapy and mitigating toxicity.Front Cell Dev Biol2026https://conductscience.org/library/papers/42199344PubMed
42140671MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stress.Genes Dev2026https://conductscience.org/library/papers/42140671PubMed
42094195Treatment outcomes and next-generation sequencing of a rare malignancy - urachal carcinoma: case report and literature review.Front Oncol2026https://conductscience.org/library/papers/42094195PubMed
42072056Alpha-Lipoic Acid Inhibits IFN-γ-Induced PD-L1 Expression in Prostate Cancer Cells and Enhances T-Cell-Mediated Anti-Tumor Cytotoxicity.Antioxidants (Basel)2026https://conductscience.org/library/papers/42072056PubMed
41972179MIZ-1 controls transcriptional programs required for BCR signaling, actin dynamics, and naïve B cell survival.Front Immunol2026https://conductscience.org/library/papers/41972179PubMed
41964004KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers.Mol Cancer2026https://conductscience.org/library/papers/41964004PubMed
41945431Targeted degradation of c-Myc through the midnolin-proteasome pathway.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41945431PubMed
41930322Nanobody-Mediated c-MYC Degradation Inhibits Tumor Cell Progression.MedComm (2020)2026https://conductscience.org/library/papers/41930322PubMed

See all 496 cited byDownload CSV of cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212NCBI Gene
AURKC6795PubTator's text mininghttps://conductscience.org/library/genes/6795NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BRD423476PubTator's text mininghttps://conductscience.org/library/genes/23476NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CDK71022PubTator's text mininghttps://conductscience.org/library/genes/1022NCBI Gene
CDK91025PubTator's text mininghttps://conductscience.org/library/genes/1025NCBI Gene
CHAF1B8208PubTator's text mininghttps://conductscience.org/library/genes/8208NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CPEB164506PubTator's text mininghttps://conductscience.org/library/genes/64506NCBI Gene
DNER92737PubTator's text mininghttps://conductscience.org/library/genes/92737NCBI Gene
EIF4E1977PubTator's text mininghttps://conductscience.org/library/genes/1977NCBI Gene
EIF4EBP11978PubTator's text mininghttps://conductscience.org/library/genes/1978NCBI Gene
FBXW755294PubTator's text mininghttps://conductscience.org/library/genes/55294NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene
KAT2A2648PubTator's text mininghttps://conductscience.org/library/genes/2648NCBI Gene
KAT510524PubTator's text mininghttps://conductscience.org/library/genes/10524NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene

See all 33 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29527331

GET https://conductscience.org/api/papers/v1/29527331/references?page=2